Scarica l'app Stockscreener
77.89
2.70%
2.05
Pre-mercato:
77.89
Precedente Chiudi:
$75.84
Aprire:
$76.73
Volume 24 ore:
1.07M
Relative Volume:
0.91
Capitalizzazione di mercato:
$12.87B
Reddito:
$8.31B
Utile/perdita netta:
$379.00M
Rapporto P/E:
36.06
EPS:
2.16
Flusso di cassa netto:
$385.00M
1 W Prestazione:
+3.88%
1M Prestazione:
+6.57%
6M Prestazione:
+17.91%
1 anno Prestazione:
+51.39%
Intervallo 1D:
$76.34
$78.86
Intervallo di 1 settimana:
$74.19
$78.86
Portata 52W:
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
Nome
Solventum Corp
Settore
Industria
Telefono
651-733-1110
Indirizzo
C/O 3M COMPANY, ST. PAUL
Confronta SOLV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
77.89 | 12.87B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
537.99 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.67 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.02 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.26 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.42 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-10-08 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | Piper Sandler | Neutral |
| 2024-09-26 | Iniziato | Wolfe Research | Peer Perform |
| 2024-09-05 | Iniziato | BTIG Research | Neutral |
| 2024-06-24 | Iniziato | Argus | Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2024-05-10 | Iniziato | BofA Securities | Neutral |
| 2024-04-10 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Iniziato | Wells Fargo | Equal Weight |
| 2024-04-02 | Iniziato | Edward Jones | Hold |
Mostra tutto
Solventum Corp Borsa (SOLV) Ultime notizie
Solventum Named a Best Company to Work for by U.S. News & World Report - Stock Titan
How Did Solventum Corporation's (NYSE:SOLV) 12% ROE Fare Against The Industry? - Yahoo Finance
With 68% ownership, Solventum Corporation (NYSE:SOLV) boasts of strong institutional backing - simplywall.st
SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum - Yahoo Finance
Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization - PR Newswire
Legacy and innovation on show as Solventum unveils new products - Dentistry UK
Keybanc Initiates Coverage of Solventum (BIT:1SOLV) with Sector Weight Recommendation - Nasdaq
Q1 Rundown: Solventum (NYSE:SOLV) Vs Other Surgical Equipment & ConsumablesDiversified Stocks - MSN
Keybanc Initiates Coverage of Solventum (SOLV) with Sector Weight Recommendation - Nasdaq
Keybanc Initiates Coverage of Solventum (LSE:0AD1) with Sector Weight Recommendation - Nasdaq
KeyBanc Initiates Solventum at Sector Weight - MarketScreener
Solventum initiated with a Sector Weight at KeyBanc - TipRanks
KeyBanc initiates Solventum stock with Sector Weight rating - Investing.com India
KeyBanc initiates Solventum stock with Sector Weight rating By Investing.com - Investing.com South Africa
SOLV's Strong Q1 Signals Turnaround: Is the Stock Worth Betting Now? - MSN
Solventum to Participate in the 2025 Goldman Sachs Health Care Conference - Kilgore News Herald
Solventum to Participate in the 2025 Goldman Sachs Health Care C - GuruFocus
Solventum Stock Earns RS Rating Upgrade - Investor's Business Daily
Ensemble and Solventum to launch autonomous coding solution for hospitals - MSN
Solventum Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Ameriprise Financial Inc. Boosts Stake in Solventum Co. (NYSE:SOLV) - Defense World
Piper Sandler Upgrades Solventum (BIT:1SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (LSE:0AD1) - Nasdaq
Ensemble and Solventum Partner to Advance Autonomous Inpatient Coding with AI - The Manila Times
Piper Sandler Upgrades Solventum (BMV:SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (SOLV) - Nasdaq
Assessing Solventum: Insights From 9 Financial Analysts - Benzinga
Piper Sandler raises Solventum stock to Overweight, target to $87 By Investing.com - Investing.com Nigeria
Piper Sandler raises Solventum stock to Overweight, target to $87 - Investing.com
Piper Sandler Upgrades Solventum to Overweight From Neutral, Adjusts Price Target to $87 From $78 - marketscreener.com
Solventum upgraded to Overweight from Neutral at Piper Sandler - TipRanks
Promising Growth and Strategic Flexibility: A Buy Recommendation for Solventum Corporation - TipRanks
After spinoff, 3M is no longer one of Minnesota’s five largest public companies - MSN
Solventum's (NYSE:SOLV) Shareholders Have More To Worry About Than Only Soft Earnings - simplywall.st
Solventum's (NYSE:SOLV) Problems Go Beyond Weak Profit - Yahoo Finance
Solventum Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
People moves: Linda Pazin joins Solventum and Mitch Haws moves to Semtech - IR Impact
Solventum To Present At BofA Securities Health Care Conference; Webcast At 5:20 PM ET - Nasdaq
Solventum sells purification business for $4.1B to pay down debt - MSN
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
Solventum’s projected $100M tariff hit prevents earnings increase - MedTech Dive
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline - MSN
Solventum, facing tariffs of up to $100 million, raises sales guidance - MSN
Solventum Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight - GuruFocus
Solventum beats first-quarter profit estimates on strong surgical product sales - MSN
Solventum Corp Azioni (SOLV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Solventum Corp Azioni (SOLV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hanson Bryan C | Chief Executive Officer |
May 13 '25 |
Option Exercise |
0.00 |
34,315 |
0 |
75,108 |
| Harris Bernard A Jr | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Edwards Shirley Ann | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '25 |
Option Exercise |
0.00 |
2,375 |
0 |
2,375 |
| DeVore Susan D. | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| ALBAN CARLOS | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '25 |
Option Exercise |
0.00 |
3,959 |
0 |
11,220 |
| Wendell Amy McBride | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| MAY KAREN J | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Mily Elizabeth | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,626 |
2.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):